BioSpace News Archive

Allarity Therapeutics, Inc. announced that the Company’s adjourned 2022 Annual Stockholders Meeting set for December 2, 2022 has been cancelled and a new meeting date for the Annual Stockholders Meeting will be held, as a virtual meeting, on January 19, 2023.

Dallas Hack , MD, CEO of VirTech Bio , will present the advancements of OxyBridge™, a novel Hemoglobin-Based Oxygen Carrier (HBOC) solution for use when tissue oxygenation is required but blood is not an option (Patent 11504417, issued 11.22.22). Dr. Hack became CEO of VirTech Bio in March 2022.

Zentalis TM Pharmaceuticals, Inc. today announced that on December 1, 2022, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 204,850 shares of the Company’s common stock to seven newly hired employees.

UroGen Announces New Data from the OLYMPUS Trial that Shows Median Durability of Response of 28.9 Months for JELMYTO ®, the Only Non-Surgical, Chemoablative Treatment for Adults with Low-Grade Upper Tract Urothelial Cancer.

Jacobio Pharma (1167.HK) will present the results of KRAS G12C inhibitor JAB-21822 as a single agent or in combination with SHP2 inhibitor JAB-3312 in preclinical cancer models in a poster session during the 2022 European Society of Medical Oncology ASIA (ESMO ASIA ) Congress from December 2-4, 2022.

G1 Therapeutics, Inc. announced the grant of inducement stock options exercisable for 14,400 shares of G1’s common stock and 9,400 restricted stock units to five hired employees under the Amended and Restated G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan.

Renalytix plc announced additional highlights from the publication of data from a clinical utility study demonstrating that use of KidneyIntelX risk assessment in the primary care setting resulted in improved clinical decision making and observed clinical outcomes for 1,686 patients in the earliest stages of diabetic kidney disease.

OraSure Technologies, Inc., a global leader in the fight against HIV, will ring the closing bell for the Nasdaq Stock Market this afternoon in honor of World AIDS Day.

Athira Pharma, Inc. announced it will host a virtual research and development event titled “Enhancing the HGF/MET System to Fight Neurodegenerative Diseases,” on December 7, 2022, from 2:00 p.m. to 3:30 p.m. EST.

Asuragen, a Bio-Techne brand and Oxford Nanopore Technologies plc, announce a collaboration to develop assays designed to deliver more accurate and reliable options for reproductive health and carrier screening.